Neuronetics, Inc. (STIM) stock forecast and price target
Price $1.39 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($1.39)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.46 | +22.6% | $162M |
| Next fiscal year ends December 31, 2027 | $-0.30 | +33.6% | $177M |
| Next quarter ends December 31, 2026 | $-0.07 | +30.0% | $44M |
| Quarter after ends March 31, 2027 | $-0.08 | +43.4% | $38M |
Consensus of the analysts covering Neuronetics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 331.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Neuronetics’s intrinsic value about 65% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Neuronetics stock price target?
The average 12-month target from 4 analysts is $6.00, 331.7% above the current price of $1.39 Targets range from $5.00 to $7.00.
Is Neuronetics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Neuronetics expected to earn?
Analysts expect EPS of $-0.46 for the fiscal year ending December 31, 2026 and $-0.30 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.